Catheter Ablation for Atrial Fibrillation: A Multicenter Clinical Trial

Wuhan University1 site in 1 country2,040 target enrollmentJanuary 2009

ConditionsAtrial Fibrillation

Overview

Phase: Phase 4
Intervention: Not specified
Conditions: Atrial Fibrillation
Sponsor: Wuhan University
Enrollment: 2040
Locations: 1
Primary Endpoint: recurrence of atrial arrhythmias (AF, AFL, AT)
Last Updated: 16 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

To compare the efficacy of different procedures, identify the optimal procedure, ablation sites, ablation endpoints and post-operative anticoagulation strategy, establish the optimal treatment strategy for atrial fibrillation.

Registry

clinicaltrials.gov

Start Date

January 2009

End Date

December 2013

Last Updated

16 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Wuhan University

Eligibility Criteria

Inclusion Criteria

•Atrial fibrillation recorded by ECG or Holter;
•Age: 18 \~ 75 years;
•Patients who are willing to enroll in the trial

Exclusion Criteria

•Patients accompanied hyperthyroidism;
•Patients with sever liver or renal dysfunction;
•Patients with sever cardiac dysfunction;
•Patients had previous radiofrequency catheter ablation in the LA or Maze surgical procedure;
•Patients with emboli in atrium;
•Pregnant woman